Literature DB >> 6805990

Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes.

A P Johnstone, J C Jensenius, R E Millard, L Hudson.   

Abstract

The capacity of B cells from patients with chronic lymphocytic leukaemia (CLL) to produce and secrete immunoglobulin following mitogen stimulation was investigated using sensitive radioimmunoassays for mu, gamma, alpha, kappa, and lambda immunoglobulin chains. Lymphocytes from seven of the 11 patients studied secreted immunoglobulin in response to pokeweed mitogen (PWM). IgM was always the major immunoglobulin and in five of the seven responders it was the only class detected; only one type of light chain was observed in most cases. This was in contrast to normal lymphocytes which secreted all classes of immunoglobulin (IgM was invariably the lowest) containing both types of light chain. Lipopolysaccharide induced immunoglobulin secretion in only one of four CLL cases. This was again IgM with only one type of light chain. The assays are therefore most probably measuring a response by the leukaemic cells. In most CLL cases, immunoglobulin secretion by the residual normal cells, which proliferate in response to mitogen, was not observed. This inability of the normal lymphocytes to differentiate fully into immunoglobulin secreting cells and the block in switching from IgM production to other classes in the leukaemic cells may both be attributable to a defect in the regulatory system of the immune response in CLL patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805990      PMCID: PMC1536416     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  In vitro functional studies of mononuclear cells in patients with CLL: evidence for functionally normal T lymphocytes and monocytes and abnormal B lymphocytes.

Authors:  T Han; B Dadey
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

2.  Maturation of mitogen-activated bone marrow-derived lymphocytes in the absence of proliferation.

Authors:  J Andersson; F Melchers
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

3.  Localization of Gm markers to different molecular regions of the Fc fragment.

Authors:  J B Natvig; M W Turner
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

4.  Lymphocyte surface immunoglobulin density and immunoglobulin secretion in vitro in chronic lymphocytic leukemia (CLL).

Authors:  Y H Chen; P Heller
Journal:  Blood       Date:  1978-09       Impact factor: 22.113

5.  Kinetics of immunoglobulin production by cultured human peripheral blood lymphocytes.

Authors:  S M McLachlan; B R Smith; R Hall
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

6.  Immunoglobulin M: pentameric Fcmu fragments released by trypsin at higher temperatures.

Authors:  A G Plaut; T B Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  1970-02       Impact factor: 11.205

7.  Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.

Authors:  V C Maino; J T Kurnick; R T Kubo; H M Grey
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

8.  Optimal conditions for polyclonal antibody secretion and DNA synthesis in human blood and spleen lymphocytes by lipopolysaccharide.

Authors:  T Kunori; O Ringdén; E Möller
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

9.  Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide.

Authors:  O Ringdén; B Rynnel-Dagöö; E M Waterfield; E Möller; G Möller
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes.

Authors:  S M Fu; N Chiorazzi; H G Kunkel; J P Halper; S R Harris
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  6 in total

1.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

2.  Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: secretion of monoclonal IgM by in vitro-induced plasmablasts.

Authors:  A C Bloem; C O van Hooff; E J Bast; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

3.  Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology.

Authors:  V Malkovska; J Murphy; L Hudson; D Bevan
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

4.  Analysis and isolation of leukaemic and residual normal B lymphocyte populations from patients with chronic lymphocytic leukaemia.

Authors:  J J Murphy; J Tooze; R E Millard; L Hudson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

5.  Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemia.

Authors:  S Karfa; R Gopal; J S Nadkarni
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

6.  Secretion of immunoglobulin by neoplastic B lymphocytes from lymph nodes of patients with lymphoma.

Authors:  F K Stevenson; E O Gregg; J L Smith; G T Stevenson
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.